252 related articles for article (PubMed ID: 34692692)
21. Endoplasmic reticulum stress related IncRNA signature predicts the prognosis and immune response evaluation of uterine corpus endometrial carcinoma.
Chen J; Shen L; Yang Y
Front Oncol; 2022; 12():1064223. PubMed ID: 36686816
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer.
Zhou H; Chen L; Lei Y; Li T; Li H; Cheng X
Curr Probl Cancer; 2021 Apr; 45(2):100660. PubMed ID: 33012523
[TBL] [Abstract][Full Text] [Related]
23. The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma.
Chen X; Zhu Z; Li X; Yao X; Luo L
Front Oncol; 2021; 11():778557. PubMed ID: 34790582
[TBL] [Abstract][Full Text] [Related]
24. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
Wang Y; Chen W; Zhu M; Xian L
Front Mol Biosci; 2021; 8():692530. PubMed ID: 34395526
[No Abstract] [Full Text] [Related]
25. A Ferroptosis-Related Signature Robustly Predicts Clinical Outcomes and Associates With Immune Microenvironment for Thyroid Cancer.
Ge M; Niu J; Hu P; Tong A; Dai Y; Xu F; Li F
Front Med (Lausanne); 2021; 8():637743. PubMed ID: 33928101
[No Abstract] [Full Text] [Related]
26. Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC.
Liu J; Geng R; Ni S; Cai L; Yang S; Shao F; Bai J
Mol Ther Nucleic Acids; 2022 Mar; 27():1036-1055. PubMed ID: 35228898
[TBL] [Abstract][Full Text] [Related]
27. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.
Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z
Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189
[TBL] [Abstract][Full Text] [Related]
28. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.
Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J
Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433
[No Abstract] [Full Text] [Related]
29. Construction of a prognostic model of luteolin for endometrial carcinoma.
Zhao J; Jiao W; Sui X; Zou J; Wang J; Lin Z
Am J Transl Res; 2023; 15(3):2122-2139. PubMed ID: 37056832
[TBL] [Abstract][Full Text] [Related]
30. Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Xu Y; Du Y; Zheng Q; Zhou T; Ye B; Wu Y; Xu Q; Meng X
Front Immunol; 2022; 13():895110. PubMed ID: 35603151
[TBL] [Abstract][Full Text] [Related]
31. FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma.
Wang Z; Xing L; Huang Y; Han P
Cancer Med; 2023 Feb; 12(3):3797-3811. PubMed ID: 36812126
[TBL] [Abstract][Full Text] [Related]
32. A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma.
Lu W; Wu Y; Huang S; Zhang D
Front Genet; 2021; 12():755486. PubMed ID: 34745224
[TBL] [Abstract][Full Text] [Related]
33. A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma.
Nie Y; Li J; Wu W; Guo D; Lei X; Zhang T; Wang Y; Mao Z; Zhang X; Song W
Front Oncol; 2021; 11():706915. PubMed ID: 34604045
[TBL] [Abstract][Full Text] [Related]
34. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
Luo H; Ma C
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33540700
[TBL] [Abstract][Full Text] [Related]
35. m
Fang F; Wang P; Huang H; Ye M; Liu X; Li Q
BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Ferroptosis-Related Signature Associated with Prognosis and Immune Infiltration in Adrenocortical Carcinoma.
Chen X; Yan L; Jiang F; Lu Y; Zeng N; Yang S; Ma X
Int J Endocrinol; 2021; 2021():4654302. PubMed ID: 34335745
[TBL] [Abstract][Full Text] [Related]
37. The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.
Liu W; Sun L; Zhang J; Song W; Li M; Wang H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33782686
[TBL] [Abstract][Full Text] [Related]
38. A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC.
Li Y; Tian R; Liu J; Ou C; Wu Q; Fu X
Front Mol Biosci; 2022; 9():833910. PubMed ID: 35558564
[No Abstract] [Full Text] [Related]
39. High expression of the ferroptosis-associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma.
Yan J; Ye G; Shao Y
J Clin Lab Anal; 2022 Apr; 36(4):e24317. PubMed ID: 35218676
[TBL] [Abstract][Full Text] [Related]
40. Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer.
Zheng M; Hu Y; Gou R; Li S; Nie X; Li X; Lin B
Mol Ther Oncolytics; 2021 Sep; 22():294-306. PubMed ID: 34553020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
